D. Pascual-Figal Et Al. , "Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study," Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology , vol.40, Paris, France, pp.939, 2019
Pascual-Figal, D. Et Al. 2019. Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study. Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology , (Paris, France), 939.
Pascual-Figal, D., Witte, K. K., Wachter, R., Belohlavek, J., Straburzynska-Migaj, E., Fonseca, C., ... Cavusoglu, Y.(2019). Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study . Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology (pp.939). Paris, France
Pascual-Figal, D. Et Al. "Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study," Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, Paris, France, 2019
Pascual-Figal, D. Et Al. "Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study." Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology , Paris, France, pp.939, 2019
Pascual-Figal, D. Et Al. (2019) . "Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study." Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology , Paris, France, p.939.
@conferencepaper{conferencepaper, author={D. Pascual-Figal Et Al. }, title={Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study}, congress name={Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology}, city={Paris}, country={France}, year={2019}, pages={939} }